This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Apr 17;145(16):1712-1713.

doi: 10.1182/blood.2024028274.

Can less differentiation drive CARs to success?

Natalie S Grover¹, Barbara Savoldo¹

Affiliations

PMID: 40244642
DOI: 10.1182/blood.2024028274

Editorial

Can less differentiation drive CARs to success?

Natalie S Grover et al. Blood. 2025.

. 2025 Apr 17;145(16):1712-1713.

doi: 10.1182/blood.2024028274.

Authors

Natalie S Grover¹, Barbara Savoldo¹

Affiliation

¹ University of North Carolina at Chapel Hill.

PMID: 40244642
DOI: 10.1182/blood.2024028274

No abstract available

PubMed Disclaimer

Comment on

HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma.
Caballero AC, Ujaldón-Miró C, Pujol-Fernández P, Montserrat-Torres R, Guardiola-Perello M, Escudero-López E, Garcia-Cadenas I, Esquirol A, Martino R, Jara-Bustamante P, Ezquerra P, Soria JM, Iranzo E, Moreno-Martinez ME, Riba M, Sierra J, Alvarez-Fernández C, Escribà-Garcia L, Briones J. Caballero AC, et al. Blood. 2025 Apr 17;145(16):1788-1801. doi: 10.1182/blood.2024026758. Blood. 2025. PMID: 39841453 Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems